Found: 14
Select item for more details and to access through your institution.
Safety, pharmacokinetics and pharmacodynamics of branebrutinib (BMS‐986195), a covalent, irreversible inhibitor of Bruton's tyrosine kinase: Randomised phase I, placebo‐controlled trial in healthy participants.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1849, doi. 10.1111/bcp.14290
- By:
- Publication type:
- Article
Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients.
- Published in:
- Liver International, 2016, v. 36, n. 2, p. 189, doi. 10.1111/liv.12964
- By:
- Publication type:
- Article
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.
- Published in:
- Nature, 2010, v. 465, n. 7294, p. 96, doi. 10.1038/nature08960
- By:
- Publication type:
- Article
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Lack of effect of multiple doses of cimetidine on estimated hepatic blood flow.
- Published in:
- Biopharmaceutics & Drug Disposition, 1987, v. 8, n. 1, p. 63, doi. 10.1002/bdd.2510080108
- By:
- Publication type:
- Article
Model-Based Drug Development: Strengths, Weaknesses, Opportunities, and Threats for Broad Application of Pharmacometrics in Drug Development.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 9, p. 31S, doi. 10.1177/0091270010377629
- By:
- Publication type:
- Article
Model-Based Drug Development Survey Finds Pharmacometrics Impacting Decision Making in the Pharmaceutical Industry.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 9, p. 20S, doi. 10.1177/0091270010377628
- By:
- Publication type:
- Article
Pharmacokinetic Interaction Between Efavirenz and Carbamazepine After Multiple-Dose Administration in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2008, v. 48, n. 8, p. 948, doi. 10.1177/0091270008319792
- By:
- Publication type:
- Article
Entecavir Pharmacokinetics, Safety, and Tolerability After Multiple Ascending Doses in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2006, v. 46, n. 11, p. 1250, doi. 10.1177/0091270006293304
- By:
- Publication type:
- Article
The Effect of Ravuconazole on the Pharmacokinetics of Nelfinavir in Healthy Male Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2006, v. 46, n. 2, p. 193, doi. 10.1177/0091270005283462
- By:
- Publication type:
- Article
The Influence of Renal Function on Hydroxyurea Pharmacokinetics in Adults With Sickle Cell Disease.
- Published in:
- Journal of Clinical Pharmacology, 2005, v. 45, n. 4, p. 434, doi. 10.1177/0091270004273526
- By:
- Publication type:
- Article
Effect of an Aluminum- and Magnesium-Containing Antacid on the Bioavailability of Garenoxacin in Healthy Volunteers.
- Published in:
- Pharmacotherapy, 2007, v. 27, n. 7, p. 963, doi. 10.1592/phco.27.7.963
- By:
- Publication type:
- Article
Clinical Pharmacology of Gatifloxacin, a New Fluoroquinolone.
- Published in:
- Clinical Infectious Diseases, 2000, v. 31, p. S51, doi. 10.1086/314061
- By:
- Publication type:
- Article
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article